Stem Cell Killer Could Lead to Triple-Negative Breast Cancer 'Game Changer'
/
June 5, 2012 - In research that has been labelled a 'game changer' in Triple Negative Breast Cancer treatment, Dr. Sandra Dunn's team at UBC identifies RSK as critical to the survival of TNBC stem cells that can drive disease recurrence.